FdaApplication
NDA 215870
Identifiers
- fda_app_no: NDA215870
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | NDA |
| approval_date | 2023-02-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 2.5MG BASE/50ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
2 products